Jiangsu Simcere Pharmaceutical Co., Ltd.
Clinical trials sponsored by Jiangsu Simcere Pharmaceutical Co., Ltd., explained in plain language.
-
New hope for hard-to-treat ovarian cancer: drug combo shows promise in late-stage trial
Disease control CompletedThis study tested whether adding the drug BD0801 to standard chemotherapy helps women with recurrent ovarian cancer that no longer responds to platinum-based treatment. The trial included 421 women with platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer. The…
Phase: PHASE3 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 08:53 UTC
-
Healthy volunteers help test new Drug's safety
Knowledge-focused CompletedThis early-stage study tested a new drug called SIM0278 in 60 healthy Chinese adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo as a single or multiple injections. The goal was to check for side effects and measure drug …
Phase: PHASE1 • Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC